{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:56:18Z","timestamp":1790949378564,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bbrc.2018.04.127","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T02:42:08Z","timestamp":1524710528000},"page":"650-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["PBX1 promotes the cell proliferation via JAK2\/STAT3 signaling in clear cell renal carcinoma"],"prefix":"10.1016","volume":"500","author":[{"given":"Xin","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.04.127_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrc.2018.04.127_bib2","first-page":"1611","article-title":"The changing natural history of renal cell carcinoma","volume":"166","author":"Pantuck","year":"2001","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.bbrc.2018.04.127_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2018.04.127_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.critrevonc.2015.07.009","article-title":"Metastatic clear cell renal cell carcinoma: a review of current therapies and novel immunotherapies","volume":"96","author":"Thomas","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2018.04.127_bib5","first-page":"2361","article-title":"Novel therapeutics for metastatic renal cell carcinoma","volume":"115","author":"Hutson","year":"2009","journal-title":"Cancer-Am. Cancer Soc."},{"key":"10.1016\/j.bbrc.2018.04.127_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10555-014-9533-1","article-title":"Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art","volume":"33","author":"Randall","year":"2014","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.bbrc.2018.04.127_bib7","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.prro.2012.01.005","article-title":"The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma","volume":"2","author":"Hunter","year":"2012","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.bbrc.2018.04.127_bib8","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ijrobp.2011.02.040","article-title":"Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma","volume":"82","author":"Zelefsky","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbrc.2018.04.127_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0092-8674(90)90658-2","article-title":"A\u00a0new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL","volume":"60","author":"Kamps","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.04.127_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0092-8674(90)90657-Z","article-title":"Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor","volume":"60","author":"Nourse","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.04.127_bib11","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1093\/nar\/25.21.4173","article-title":"Analysis of TALE superclass homeobox genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a novel domain conserved between plants and animals","volume":"25","author":"Burglin","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2018.04.127_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0092-8674(93)90463-Z","article-title":"Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice","volume":"74","author":"Dedera","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.04.127_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1101\/gad.5.3.358","article-title":"The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials","volume":"5","author":"Kamps","year":"1991","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2018.04.127_bib14","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1128\/MCB.14.12.8304","article-title":"Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable","volume":"14","author":"Monica","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.04.127_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0168-9525(96)10026-3","article-title":"Extra specificity from extradenticle: the partnership between HOX and PBX\/EXD homeodomain proteins","volume":"12","author":"Mann","year":"1996","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2018.04.127_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","article-title":"Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression","volume":"19","author":"Fukuda","year":"2011","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2018.04.127_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2016.08.023","article-title":"Gemcitabine treatment promotes pancreatic cancer stemness through the Nox\/ROS\/NF-kappaB\/STAT3 signaling cascade","volume":"382","author":"Zhang","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2018.04.127_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2016.08.023","article-title":"Gemcitabine treatment promotes pancreatic cancer stemness through the Nox\/ROS\/NF-kappaB\/STAT3 signaling cascade","volume":"382","author":"Zhang","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2018.04.127_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0925-4773(93)90045-Y","article-title":"Dpbx, a new homeobox gene closely related to the human proto-oncogene pbx1 molecular structure and developmental expression","volume":"41","author":"Flegel","year":"1993","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bbrc.2018.04.127_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0092-8674(93)90731-5","article-title":"Extradenticle, a regulator of homeotic gene activity, is a homolog of the homeobox-containing human proto-oncogene pbx1","volume":"74","author":"Rauskolb","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.04.127_bib21","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1038\/sj.onc.1204592","article-title":"The role of E2A-PBX1 in leukemogenesis","volume":"20","author":"Aspland","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.04.127_bib22","doi-asserted-by":"crossref","first-page":"s206","DOI":"10.2741\/1030","article-title":"E2A basic helix-loop-helix transcription factors in human leukemia","volume":"8","author":"LeBrun","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbrc.2018.04.127_bib23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1535-7163.MCT-14-0800","article-title":"Targeted blockade of JAK\/STAT3 signaling inhibits ovarian carcinoma growth","volume":"14","author":"Gritsina","year":"2015","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2018.04.127_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3892\/ijo.2013.2017","article-title":"Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2\/STAT3 signaling pathway in an ovarian cancer cell line","volume":"43","author":"Benabbou","year":"2013","journal-title":"Int. J. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18309082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18309082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T08:19:21Z","timestamp":1563869961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18309082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0006291X18309082"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.127","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PBX1 promotes the cell proliferation via JAK2\/STAT3 signaling in clear cell renal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}